Recombinant human IL-21 protein (Active, HEK293), Biotin Conjugated
Applications
| Overview | |
| Catalog # | bs-48033P-Biotin-50ug |
| Product Name | Recombinant human IL-21 protein (Active, HEK293), Biotin Conjugated |
| Applications | Others |
| Specifications | |
| Conjugation | Biotin |
| Source | Recombinant human IL-21 protein is expressed in HEK293 |
| Storage Buffer | Lyophilized from 0.22um filtered solution in 20mM PB (pH 7.4). 5% trehalose is added as a protectant before lyophilization. |
| Storage Condition | The product should be stored at -70°C or -20°C. |
| Target | |
| Gene ID | 59067 |
| Swiss Prot | Q9HBE4 |
| Background | IL-21 is a typical family I cytokine with broad pleiotropic actions and is primarily produced by T follicular helper cells, Th17, and natural killer T cells in response to antigenic stimulation. Il-21 generally enhances antigen-specific responses of immune cells. It controls the activation, proliferation, differentiation, cytotoxicity, and survival of various target immune cells. Additionally, IL-21 promotes the anti-tumor activity of CD8+ T-cells and NK cells. IL-21 elicits its effect through binding to IL-21R, which also contains the gamma chain found in other cytokine receptors such as IL-2, IL-4, IL-7, IL-9 and IL-15. IL-21/IL-21R interaction triggers a cascade of events, which includes activation of the tyrosine kinases JAK1 and JAK3, followed by activation of the transcription factors STAT1 and STAT3. Recombinant Human IL-21 is a 15.4 kDa protein consisting of 132 amino acid residues |